Vor Biopharma Inc. (VOR) — DEF 14A Filings
All DEF 14A filings from Vor Biopharma Inc.. Browse 3 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (3)
-
Vor Bio Seeks Reverse Split, Boosts Equity Plan Shares
— Aug 8, 2025 Risk: high
Vor Biopharma Inc. (VOR) is holding a Special Meeting of Stockholders on August 25, 2025, to address three critical proposals. The first proposal seeks approval -
Vor Biopharma Files Definitive Proxy Statement
— Apr 8, 2025 Risk: low
Vor Biopharma Inc. filed its definitive proxy statement (DEF 14A) on April 8, 2025, for the fiscal year ending December 31, 2024. The filing, which does not req -
Vor Biopharma Inc. Announces 2024 Annual Meeting of Stockholders
— Apr 9, 2024 Risk: low
Vor Biopharma Inc. (VOR) filed a Proxy Statement (DEF 14A) with the SEC on April 9, 2024. Annual Meeting scheduled for May 23, 2024, held virtually. Election of
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX